Status:
COMPLETED
Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan
Lead Sponsor:
Pfizer
Conditions:
Infections, Nosocomial
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan
Eligibility Criteria
Inclusion
- infection due to methicillin-resistant Staphylococcus aureus
Exclusion
- hypersensitivity to linezolid
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00150332
Start Date
January 1 2003
End Date
January 1 2006
Last Update
May 10 2011
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Kamogawa, Chiba, Japan, 296-0041
2
Pfizer Investigational Site
Fukuoka, Fukuoka, Japan, 811-0213
3
Pfizer Investigational Site
Fukuoka, Fukuoka, Japan, 813-0025
4
Pfizer Investigational Site
Onga-gun, Fukuoka, Japan, 807-0051